Results 151 to 160 of about 14,396 (200)

Genomic and phenotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from patients and trolleys and their potential connections in an intensive care unit. [PDF]

BMC Microbiol
Min P, Xu H, Pan H, Chen S, Yao J, Li S, Ding X, Hua X, Li X, Yu Y, Zhou H, Liu H.   +11 more
europepmc   +1 more source

Interpretable Machine Learning for Predicting Cefoperazone-Sulbactam-Associated Coagulation Abnormalities in Elderly Inpatients: A Dual-Center Retrospective Study. [PDF]

Diagnostics (Basel)
Li Y, Deng H, Gu Y.
europepmc   +1 more source

Differences and trends in pathogens between ventilator-associated pneumonia and non-ventilator-associated pneumonia: data from 61 hospitals in Suzhou, China, 2020-2024. [PDF]

BMJ Open
Yang J, Song X, Wang Y, Zhang J, Jin M.
europepmc   +1 more source

Polymicrobial Multidrug-Resistant Infection and Fatal Bowel Ischemic Perforation After Urgent Heart Transplantation in a VA-ECMO-Bridged Recipient: A Case Report. [PDF]

Infect Drug Resist
Jia Y, Zhu Y, Cai H.
europepmc   +1 more source

Effects of Antibiotic-Induced Gut Microbiota Dysbiosis on Arsenic Bioaccumulation and Transformation in Mice and Its Potential Mechanisms. [PDF]

Environ Health (Wash)
Jiang X, Zhao F, Li R, Xiong S, Xiao P, Wang P, Gao H, Wu Y, Xiao K, Cai X, Yin N, Sun G, Cui Y.   +12 more
europepmc   +1 more source

Penetration of cefoperazone into ascites

European Journal of Clinical Pharmacology, 1989
The pharmacokinetics of cefoperazone was studied in eleven cirrhotic patients with ascites after i.v. administration of a single dose of 15 mg.kg-1 (n = 7) or after three doses of 15 mg.kg-1 given at 12 h intervals (n = 4). The concentrations of cefoperazone in serum and ascitic fluid were determined by HPLC.
Van Gossum, André, Quenon, Marianne, Van Gossum, Marc, Herchuelz, André, Thys, Jean-Pierre   +4 more
openaire   +4 more sources

Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study

Expert Opinion on Drug Safety, 2020
Objectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding. Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with ...
Yu Wu, Jing Tan
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of Cefoperazone

Drugs, 1981
The pharmacokinetics of cefoperazone in normal subjects, and in patients with hepatic and renal dysfunction are reviewed. After intravenous administration of 2 g of cefoperazone, levels in serum ranged from 202 to 375 microgram/ml depending on the period of drug administration.
W A, Craig, A U, Gerber
openaire   +2 more sources

Pharmacokinetics of cefoperazone in horses

Journal of Veterinary Pharmacology and Therapeutics, 1996
The pharmacokinetics and bioavailabilty of cefoperazone (CPZ) were studied following intravenous (IV) and intramuscular (IM) administration of single doses (30 mg/kg) to horses. Concentrations in serum, urine and synovial fluid samples were measured following IV administration.
A L, Soraci, O N, Mestorino, J O, Errecalde   +2 more
openaire   +2 more sources